Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate
Portfolio Pulse from Benzinga Newsdesk
Nephros reported Q1 2024 earnings with a GAAP EPS of $(0.02), beating estimates by 50% but missed sales estimates with $3.522M against a forecast of $3.734M. This represents a 33.33% improvement in EPS and a 4.73% decrease in sales year-over-year.
May 09, 2024 | 9:44 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Nephros beat EPS estimates but missed on sales for Q1 2024, showing mixed financial performance.
Nephros's EPS beat may positively impact investor sentiment due to better-than-expected profitability. However, the miss on sales forecasts could temper optimism, suggesting potential challenges in revenue growth. The mixed results lead to a neutral short-term impact expectation, as the positive EPS beat is offset by the negative sales miss.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100